BERKELEY HEIGHTS, N.J., March 13, 2014 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (“Cyclacel” or the “Company”), a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders, will announce fourth quarter and full year 2013 financial results on Tuesday, March 25, 2014. The Company will host a conference call and live webcast at 4:30 pm Eastern time on the same day.
Help employers find you! Check out all the jobs and post your resume.
